The Serum Institute of Life Sciences will double its investment in one of Biocon Ltd's units, giving it access to 100 million doses of vaccines annually along with the distribution rights to Serum's vaccine portfolio, the Indian biopharma firm said today. Serum Institute of Life Sciences is a unit of the Serum Institute of India, the world's biggest vaccine maker. Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said. Biocon signed an agreement in September 2021 to offer about a 15% stake in Biocon Biologics to the Serum Institute of Life Sciences. Source: NDTV
17 Apr 12:27 PM
17 Apr 12:27 PM
Diesel Price had declined across the country after over a month on Wednesday. However, the petrol prices have remained unchanged for Read more
17 Apr 12:27 PM
Diesel Price had declined across the country after over a month on Wednesday. However, the petrol prices have remained unchanged for Read more
reports
We will suggest you loops to join based on your interests.
of {News }
Insufficient balance. Please click here to top up wallet.
Current balance: $ 0
17 Apr 12:27 PM
Don't have an account? Register
Mobile not accessible? Login with email
Email not accessible? Login with SMS
Complete your blue tick verification to access core functionalities of the site.
Complete your blue tick verification to access core functionalities of the site.
This is your popup content.